I am an 85-year-old woman in relatively good health. I had been taking raloxifene for approximately 45 years. My doctor at the time said that since I had ...

A phase III trial that compared bazedoxifene, a novel selective estrogen receptor modulator, with raloxifene and placebo has shown that bazedoxifene prevents bone loss and increases BMD in ...

By contrast, no increased stroke risk was associated with raloxifene use in patients with osteoporosis. Previous studies have hinted at a relationship between the use of raloxifene (a selective ...

The pharmacokinetics of raloxifene were investigated in over 1500 women in clinical trials (Table 1). [16] Although most of the women were white and postmenopausal, interpatient variability of ...

Unlimited access to all stories from nashuatelegraph.com on your computer, tablet or smart phone. Access nashuatelegraph.com, view our digital edition or use our Full ...

The pharmacology, pharmacokinetics, clinical efficacy, adverse effects, and therapeutic role of raloxifene hydrochloride are reviewed. Raloxifene is a selective estrogen-receptor modulator (SERM ...